Peripheral Arterial Disease Trial, Recruiting (NCT04117230)

Peripheral Arterial Disease Trial, Recruiting NCT04117230 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT04117230 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 years or older.
People who have a medical need for a specific type of heart support device, such as a peripheral VA-ECMO (a machine that temporarily takes over the work of the heart and lungs), a microaxial flow pump called an IMPELLA (a small device that helps the heart pump blood), or newer devices that support the left side of the heart connected to the main blood vessel leaving the heart.
People who have given signed consent to participate, or whose family member has given consent on their behalf, or where the ethics committee has approved waiving the consent requirement.

Who may not be able to join:

There are no stated exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Lukas C Hunziker Munsch, Prof MD, University of Bern

Phone: 0041316322111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04117230

Sponsor: Insel Gruppe AG, University Hospital Bern

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 0041316322111

More information: https://clinicaltrials.gov/study/NCT04117230

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 years or older.
People who have a medical need for a specific type of heart support device, such as a peripheral VA-ECMO (a machine that temporarily takes over the work of the heart and lungs), a microaxial flow pump called an IMPELLA (a small device that helps the heart pump blood), or newer devices that support the left side of the heart connected to the main blood vessel leaving the heart.
People who have given signed consent to participate, or whose family member has given consent on their behalf, or where the ethics committee has approved waiving the consent requirement.

Who may not be able to join:

There are no stated exclusion criteria for this trial.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Insel Gruppe AG, University Hospital Bern

Registry

ClinicalTrials.gov

Start date

9 August 2019

Est. completion

31 August 2034

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Number of deceased participants at 1 month after cardiogenic shock

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov